Marketers survey the pluses and minuses of the platform's new 280-character limit.
Teva reports lower-than-expected Q3 earnings; BI and Dicerna partner in NASH drug development; AstraZeneca's experimental asthma drug fails in Phase-III
Two key creators from Ready Set Rocket share how a thoughtful execution can destigmatize mental illness.
AI complements what we in pharma have always done best — respond to medical needs quickly and find solutions.
The e-giant is reportedly doing everything from starting secret labs and online pharmacies to redefining the hospital experience and democratizing health data.
The CEO and founder of Antidote talks about what inspired him to start the company, which recently received funding from Merck.
Facebook itself has more than six million health-related groups.
Too few of the billions of sites online are usable for disabled people, says AudioEye's CEO.
The rise of voice technology platforms and the connected home has turned the discussion of a brand's voice from metaphorical to physical.
Facebook chief operating officer Sheryl Sandberg has said that in turbulent times the social network must do more than simply connect people.
Rosa talks about the wearable technology company's health and fitness plans and other areas of expansion.
Alexion to cut 600 jobs; Sage Therapeutics' experimental seizure drug fails to meet expectations; Apple is interested in medical and health activity
Teva names new CEO; Allergan transfers Restasis patent to skirt competition; Google invests in oncology
The coming digital revolution will change a lot of things, but I guarantee this: It won't replace the importance of the patient-physician relationship.
Consumers younger than the age of 45 were most likely to use an app developed by their health plan.
Alone among the best-known social platforms, Snapchat has failed to generate much enthusiasm from pharma. Here's why — and here's why that may change.
Calman is joining the technology company as VP of comms for Watson Health.
Facebook is ramping up its video offering as a stronger rival to YouTube and Snapchat with the launch of its redesigned video tab.
Celgene and Agios secure FDA approval for AML drug Idhifa; GSK hires chief digital and technology officer; Pfizer wants tax reform before M&A engagement
FDA launches digital health pre-certification pilot; J&J's experimental RA drug raises safety concerns; AstraZeneca gets breakthrough status for Imfinzi
Frustrated by its inability to empathize with patients, pharma has turned to tech to teach providers and caregivers what illness really feels like.
Novo Nordisk and Roche are two examples of drugmakers that are turning to digital-health startups to better engage with patients and mine valuable real-world evidence.
The Pikachu-catching phenomenon popularized AR and made the technology much more accessible.
AstraZeneca CEO reportedly moving to Teva; the FDA reverses on approval for Amicus drug; Merck names winners of Alexa challenge
Trump administration considers outcomes-based approach to lower drug prices; Sanofi to acquire vaccines biotech; Nestle partners with Enterome to develop microbiome-based diagnostics
Apple reportedly working to bring EMRs to iPhone; FDA to study disclosures in ads; Trump admin discussing drug price EO
Google invests in European biotechs; hospitals that restrict sales-rep visits more likely to prescribe cheaper generics; AI could help doctors with new research
The FDA-approved app will allow MS patients to share their medication injection history with HCPs.
Consent forms and reimbursement are the main deterrents of offering the service.
With physicians spending nearly four hours a day on their electronic health records, experts say voice assistants could help reduce their workload one day.